Effect of Mesenchymal Stem Cells in Primary Knee Osteoarthritis

Status Recruiting

Clinical Trial Summary

Osteoarthritis (OA) is the most prevalent chronic joint disorder worldwide and is associated with significant pain and disability. Incidence and prevalence of osteoarthritis rise with increasing age. The prevalence of OA knee in Bangladesh seems to be higher due to poor working conditions, heavy physical labor, and occupational injuries which increase in the future. This will ultimately create a higher clinical and socioeconomic burden on the population and national economy. The course of the disease varies but is often progressive. OA of the knee is one of the common self-reported musculoskeletal pain conditions causing patients to visit the Physical Medicine and Rehabilitation (PM&R) department, at BSMMU. The primary objectives of knee OA treatment focus on pain reduction, and joint mobility improvement, as well as the reduction of disease progression and preserving patients' independence and quality of life. Current treatments aim at alleviating these symptoms by several different methods: Non-pharmacological treatments, Pharmacological treatments, and Invasive interventions. Mesenchymal stem cells (MSCs) therapies for knee osteoarthritis are being investigated in various corners of the world. Both positive and negative findings were observed in that research. Although, the effectiveness of MSCs in KOA is not yet well known. Some studies found MSCs effective, and safe in KOA, and it has the potential to regenerate/heal degraded joint cartilage. MSCs can differentiate into cartilage tissue. Furthermore, MSCs have been shown to have paracrine anti-inflammatory and immunomodulatory effects by producing different growth factors and cytokines. This therapeutics option is under investigation to date. The objective of this trial is to find the effectiveness, safety, and dose difference of adipose tissue-derived stem cells (AT-MSCs) therapy for the treatment of knee osteoarthritis (KOA). But in fact, there is no published data about the effectiveness of autologous adipose tissue-derived mesenchymal stem cells injection on pain, joint functioning, and femoral cartilage thickness in the management of knee osteoarthritis in Bangladesh. Henceforth, this trial will generate new knowledge about the effectiveness, safety, and appropriate dose of AT-MSCs for KOA. So this research will be helpful to generate evidence-based information for an effective treatment option for the management of KOA.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05783154
Study type	Interventional
Source	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Contact	Moshiur Rahman Khasru, MBBS, FCPS
Phone	+8801716045646
Email	drkhasrupmr@bsmmu.edu.bd
Status	Recruiting
Phase	Phase 2/Phase 3
Start date	September 16, 2022
Completion date	September 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06232018` - A Comparison of 2-octyl Cyanoacrylate Skin Adhesive and Polyester Mesh for Wound Closure in Total Knee Arthroplasty, A Randomized Controlled Study	N/A
Recruiting	`NCT02200107` - Integrated Treatment Program for Osteoarthritis of the Knee	N/A
Completed	`NCT02833545` - Safety and Efficacy of Intra-articular Ozone Injections for Knee Osteoarthritis	Phase 4
Recruiting	`NCT01569230` - Efficacy and Safety Study of Individualized and Standardized Acupuncture Treatment for Knee Osteoarthritis	N/A
Completed	`NCT02314715` - Neuromuscular Control in Knee Osteoarthritis	N/A
Active, not recruiting	`NCT03548792` - Comparison of an Old Versus a New Total Knee Replacement	N/A
Completed	`NCT02285725` - Microdrilling Surgery for Full Thickness Chondral Lesions of the Knee Augmented With Concentrated Bone Marrow Aspirate, Platelet Rich Plasma and Hyaluronic Acid	N/A
Completed	`NCT02544802` - Mesenchymal Stem Cell Treatment for Primary Osteoarthritis Knee	Phase 1
Completed	`NCT02919020` - Efficacy of Proprioceptive Neuromuscular Facilitation in Older Women With Gonarthrosis	N/A
Completed	`NCT02050438` - How Total Knee Prosthesis Dessigns Influence in Quality of Live	N/A
Completed	`NCT01492660` - Echogenic Versus Stimulating Needle and Catheter for Sciatic Blocks	Phase 3
Completed	`NCT01934218` - Gel-One Treatment in Knee Osteoarthritis	N/A
Completed	`NCT04324931` - Effect of Biomechanical Correction in Medial Tibiofemoral Joint Osteoarthritis	N/A
Not yet recruiting	`NCT05742061` - Intra-articular Platelet Rich Plasma vs Corticosteroid in Treatment of Knee Osteoarthritis Patients	Early Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.